214 related articles for article (PubMed ID: 38114977)
21. The Prognostic Significance of NEK2 in Hepatocellular Carcinoma: Evidence from a Meta-Analysis and Retrospective Cohort Study.
Cheng Y; Chen X; Ye L; Zhang Y; Liang J; Liu W; Zhou B; Zheng S; Huang Y; Chen G; Deng Y; Zhang Q; Yang Y
Cell Physiol Biochem; 2018; 51(6):2746-2759. PubMed ID: 30562736
[TBL] [Abstract][Full Text] [Related]
22. Prognostic value of SPARC in hepatocellular carcinoma: A systematic review and meta-analysis.
Yang X; Xia Y; Wang S; Sun C
PLoS One; 2022; 17(8):e0273317. PubMed ID: 35981080
[TBL] [Abstract][Full Text] [Related]
23. Prognostic value of circulating tumor cells associated with white blood cells in solid cancer: a systematic review and meta-analysis of 1471 patients with solid tumors.
Ju M; Gao Z; Gu G; Huang H; Sun A; Zheng C; Li H; Zhang Y; Li K
BMC Cancer; 2023 Dec; 23(1):1224. PubMed ID: 38087278
[TBL] [Abstract][Full Text] [Related]
24. Prognostic role of galectins expression in patients with hepatic cancer: A meta-analysis.
Shao Q; He J; Chen Z; Wu C
Medicine (Baltimore); 2020 Apr; 99(15):e19622. PubMed ID: 32282710
[TBL] [Abstract][Full Text] [Related]
25. Low DMT1 Expression Associates With Increased Oxidative Phosphorylation and Early Recurrence in Hepatocellular Carcinoma.
Hoki T; Katsuta E; Yan L; Takabe K; Ito F
J Surg Res; 2019 Feb; 234():343-352. PubMed ID: 30527495
[TBL] [Abstract][Full Text] [Related]
26. Prognostic value of preoperative lymphocyte-related systemic inflammatory biomarkers in upper tract urothelial carcinoma patients treated with radical nephroureterectomy: a systematic review and meta-analysis.
Shao Y; Li W; Wang D; Wu B
World J Surg Oncol; 2020 Oct; 18(1):273. PubMed ID: 33097052
[TBL] [Abstract][Full Text] [Related]
27. Expression of carbonic anhydrase 9 is a novel prognostic marker in resectable hepatocellular carcinoma.
Kang HJ; Kim IH; Sung CO; Shim JH; Yu E
Virchows Arch; 2015 Apr; 466(4):403-13. PubMed ID: 25577552
[TBL] [Abstract][Full Text] [Related]
28. miR-122 targets pyruvate kinase M2 and affects metabolism of hepatocellular carcinoma.
Liu AM; Xu Z; Shek FH; Wong KF; Lee NP; Poon RT; Chen J; Luk JM
PLoS One; 2014; 9(1):e86872. PubMed ID: 24466275
[TBL] [Abstract][Full Text] [Related]
29. Cancer stem cell markers predict a poor prognosis in renal cell carcinoma: a meta-analysis.
Cheng B; Yang G; Jiang R; Cheng Y; Yang H; Pei L; Qiu X
Oncotarget; 2016 Oct; 7(40):65862-65875. PubMed ID: 27588469
[TBL] [Abstract][Full Text] [Related]
30. The prognostic significance of microRNA-221 in hepatocellular carcinoma: An updated meta-analysis.
Liu W; Hu K; Zhang F; Lu S; Chen R; Ren Z; Yin X
Int J Biol Markers; 2021 Jun; 36(2):17246008211032689. PubMed ID: 34374576
[TBL] [Abstract][Full Text] [Related]
31. GLUT1 and ASCT2 as Predictors for Prognosis of Hepatocellular Carcinoma.
Sun HW; Yu XJ; Wu WC; Chen J; Shi M; Zheng L; Xu J
PLoS One; 2016; 11(12):e0168907. PubMed ID: 28036362
[TBL] [Abstract][Full Text] [Related]
32. Prognostic values of microRNA-130 family expression in patients with cancer: a meta-analysis and database test.
Peng Z; Duan F; Yin J; Feng Y; Yang Z; Shang J
J Transl Med; 2019 Oct; 17(1):347. PubMed ID: 31640738
[TBL] [Abstract][Full Text] [Related]
33. Monocarboxylate transporter 4 predicts poor prognosis in hepatocellular carcinoma and is associated with cell proliferation and migration.
Gao HJ; Zhao MC; Zhang YJ; Zhou DS; Xu L; Li GB; Chen MS; Liu J
J Cancer Res Clin Oncol; 2015 Jul; 141(7):1151-62. PubMed ID: 25446815
[TBL] [Abstract][Full Text] [Related]
34. Prognostic value of PIVKA-II in hepatocellular carcinoma patients receiving curative ablation: A systematic review and meta-analysis.
Zhang D; Liu Z; Yin X; Qi X; Lu B; Liu Y; Hou J
Int J Biol Markers; 2018 Aug; 33(3):266-274. PubMed ID: 29658364
[TBL] [Abstract][Full Text] [Related]
35. Co-expression of PKM2 and TRIM35 predicts survival and recurrence in hepatocellular carcinoma.
Chen Z; Lu X; Wang Z; Jin G; Wang Q; Chen D; Chen T; Li J; Fan J; Cong W; Gao Q; He X
Oncotarget; 2015 Feb; 6(4):2538-48. PubMed ID: 25576919
[TBL] [Abstract][Full Text] [Related]
36. Prognostic effect of albumin-to-alkaline phosphatase ratio on patients with hepatocellular carcinoma: a systematic review and meta-analysis.
Zhang X; Xin Y; Chen Y; Zhou X
Sci Rep; 2023 Jan; 13(1):1808. PubMed ID: 36720974
[TBL] [Abstract][Full Text] [Related]
37. Sarcopenia Predicts Prognosis of Patients Undergoing Liver Resection for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.
Zhang H; Zhang L; Wang Y; Zou J; Zhang T
Nutr Cancer; 2023; 75(3):776-784. PubMed ID: 36537813
[TBL] [Abstract][Full Text] [Related]
38. The prognostic significance of pretreatment serum γ-glutamyltranspeptidase in primary liver cancer: a meta-analysis and systematic review.
Ou Y; Huang J; Yang L
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30389711
[No Abstract] [Full Text] [Related]
39. lncRNAs as prognostic molecular biomarkers in hepatocellular carcinoma: a systematic review and meta-analysis.
Zheng C; Liu X; Chen L; Xu Z; Shao J
Oncotarget; 2017 Aug; 8(35):59638-59647. PubMed ID: 28938667
[TBL] [Abstract][Full Text] [Related]
40. Prognostic Significance of the Metabolic Marker Hexokinase-2 in Various Solid Tumors: A Meta-Analysis.
Liu Y; Wu K; Shi L; Xiang F; Tao K; Wang G
PLoS One; 2016; 11(11):e0166230. PubMed ID: 27824926
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
